2023 Moores Annual Scientific Retreat
|
This year's program features (1) a special presentation by Dr. John Carethers, Distinguished Professor of Medicine and Vice Chancellor for Health Sciences at UC San Diego, (2) a keynote address by Dr. Cheryl Anderson, Professor and Dean of the Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego, (3) presentations of breakthrough research from accomplished and junior UC San Diego, Rady Children's Hospital, and San Diego State University scientists, (4) a poster session and poster awards, and (5) a Shark Tank-like competition for a Scientific Retreat Pilot Project Award. Visit Website»
|
American Society of Preventive Oncology (ASPO) 2024 Annual Meeting Abstract Submission Now Open
|
The 48th ASPO Annual Meeting will be held March 17–19, 2024 at the Swissôtel Chicago. All members and non-members are encouraged to participate with either an oral or poster presentation. Presentation abstracts are due Tuesday, October 17 by 11:59 p.m. PST. Submit Abstract»
|
University of California Cancer Consortium (UCCC) Molecular Tumor Board (MTB) Fall 2023 Relaunch
|
The UCCC MTB brings together precision oncology experts from across the UC system to share available biomarker-driven therapies for individual patients and ensure awareness of the latest cutting-edge treatment options in cancer care. Read More»
|
Napoleone Ferrara, M.D. Awarded the 2023 Keio Medical Science Prize
|
Keio University in Tokyo, Japan’s oldest private university, annually awards the Keio Medical Science Prize to recognize researchers who have made outstanding contributions to the fields of medicine and the life sciences. The Keio is the only prize of its kind awarded by a Japanese university, and nine Keio recipients subsequently have been awarded Nobel Prizes. The 28th Keio Medical Science Prize has been awarded to Moores Member Napoleone Ferrara, M.D. and Kyoto University's Kazutoshi Mori, Ph.D. Read More»
|
|
|
October 3, 2023 | 12:00 p.m.
Leichtag Biomedical Research Building, Room 107
|
October 4, 2023 | 12:00 p.m.
Moores Comer Commons
|
October 5, 2023 | 4:00 p.m. to 6:00 p.m.
Design & Innovation Building, Room 208
|
October 10, 2023 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons
|
|
|
UC San Diego Division of Graduate Education and Postdoctoral Affairs Postdoctoberfest 2023
|
Postdoctoberfest is UC San Diego’s month long celebration of its postdocs. Please join in recognizing the valuable contributions postdocs make to research, the campus, and society. Visit the Postdoctoberfest website to learn more about the events taking place during October.
|
CRTEC Speed Mentoring Workshop
|
October 12, 2023 | 12:00 to 1:00 p.m.
|
Moores Cancer Research Training and Education Coordination (CRTEC) Speed Mentoring Workshops for 2023–2024 will resume Thursday, October 12, 2023. This kick-off workshop will feature Dr. Barbara Parker, Dr. Eyal Oreni, and Dr. Dwayne Stupack. All students, postdocs, and junior faculty are welcome to attend.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
MRA is pleased to announce an RFP for pre-clinical, translational, and early clinical research to produce high-impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment. Proposals must address a shortcoming in translational science (i.e., turning scientific discoveries into tools and/or treatments for high-risk individuals and patients with melanoma). Successful proposals will describe proposed research that applies important basic and preclinical discoveries to the near-term development of clinical trials and studies to improve melanoma detection, prevention, diagnosis, and/or treatment. Proposals for clinical studies to test well-defined and clearly articulated hypotheses are welcome and should be accompanied by a brief protocol synopsis and timeline that includes milestones. Eligibility and deadlines vary, depending on award type.
Deadline: Multiple—depending on award; see RFP for details.
|
For this NOFO, NCI encourages proposed projects that promote transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. These projects should (1) overcome major barriers in cancer biology and/or oncology, using nanotechnology, and (2) feature mechanistic studies to expand the fundamental understanding of nanomaterial and/or nano-device interactions with biological systems. These studies must be relevant to either the delivery of nanoparticles and/or nano-devices to desired and intended cancer targets in vivo and/or characterization of detection and diagnostic devices and sensors in vitro. IRCN awards are expected to produce fundamental knowledge to aid future and more informed development of nanotechnology-based cancer interventions. The clinical translation of these interventions is beyond the scope of this NOFO.
Deadline: November 3, 2023; May 3, 2024; November 4, 2024; May 5, 2025
|
Tower Cancer Research Foundation supports forward thinking research work in Southern California. The Tower Career Development Award supports young investigators to continue their laboratory studies, while improving their ability to secure further funding. The Tower Scientific Advisory Board evaluates award proposals based on the following criteria: novelty of hypothesis; scientific quality; potential for revealing something meaningful about cancer; feasibility of the proposal; evidence of institutional support for the proposed project.
Deadline: November 6, 2023
|
The purpose of this award is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award (1) facilitates the sucessful transition of talented graduate students to cancer research postdoctoral appointments and (2) provides career development activities relevant to becoming independent cancer researchers.
Deadline: November 17, 2023 and November 19, 2024
|
|
|
JAMA Oncology
Rana R. McKay, M.D. (Solid Tumor Therapeutics)
|
Gastroenterology
Shailja Shah, M.D., M.P.H. (Cancer Control Program)
|
Cell Host & Microbe
Bjoern Peters, Ph.D. (Structural and Functional Genomics) and Alessandro Sette, Ph.D. (La Jolla Institute for Immunology)
|
|
|
CA111001: A Phase I First-in-human Study of BMS986406 as Monotherapy and Combination Therapies in Participants with Advanced Malignant Tumors
|
PI: Sandip P. Patel, M.D.
NCT: NCT05298592
|
|
|
CLINICAL TRIALS OFFICE TRANSFORMATION INITIATIVE |
-
Job postings for new career opportunities in Data Analytics, Clinical Trials Budgeting, and Network Sites Operations will appear next week, which will offer pathways to specialize and take on new roles integral to the CTO’s transformation and future performance. Communications will be sent to CTO employees when jobs are posted, and CTO encourages you to apply for positions that align with your skillsets and interests.
-
The next CTO Town Halls will be scheduled for mid-October; one will be for MCC faculty, and the other for CTO staff. The Town Halls will celebrate successes and provide updates on the progress of the transformation. Time will be allotted to address questions. Please be on the lookout for the calendar invitation coming soon.
-
Forty-four trials have entered Fast Lane, six of which have been activated to date across the Lung, Breast, GU and Gyn teams. CTO thanks the cross-functional teams across campus for their outstanding efforts to prioritize these high-priority trials for Moores patients.
-
The working groups for prioritized Data/Technology initiatives began this week, targeting Reporting/Dashboarding, System Usage and Integration, and Service Request Optimization. The first round of process changes have been initiated, with a go-live of the new Disease Team Protocol Review process set for mid-October. Process improvement opportunities will continue this fall, and CTO will highlight these areas of improvement in future communications.
- Keep the feedback coming. CTO encourages you to continue working with managers and sharing feedback, as this will inform future communications and the upcoming Town Hall topics.
|
|
|
EQUITY, DIVERSITY, AND INCLUSION (EDI)
|
Predictive Modeling in Biology and Medicine Conference
|
November 17–19, 2023 | University of California, Riverside
|
The conference will showcase recent progress in mathematical and computational modeling of biological systems, model translational predictions in biology and medicine, and data-driven and machine learning methodologies in biology. The conference will not only bring together researchers at different stages of their career to exchange ideas and novel approaches, but also promote interdisciplinary collaborations that target EDI. Indeed, a special sub-workshop on developing EDI for in education and research will be held on the first day, November 17, 2023.
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
National Hispanic Heritage Month
|
Join COE in celebrating National Hispanic Heritage Month from September 15 to October 15, 2023. Below are events and webinars that are open to the entire community. COE looks forward to your participation!
|
- 9/28—ACS Cancer Disparities Forum (Virtual)
-
10/4—Community Health and Resource Fair at the Jackie Robinson Family YMCA (Liver Cancer Awareness Month and Breast Cancer Awareness Month)
- 10/7—Community Outreach at Dia de la Mujer Festival
|
National Hispanic Heritage Month Social Media Spotlights
|
COE is calling all Hispanic and Latine researchers to be featured on social media and in newsletters in honor of National Hispanic Heritage Month. If you would like to participate, then email Maritza Gomez at mag075@health.ucsd.edu and provide (1) your name, (2) your credentials, (3) one to two sentences about what you study/research, and (4) something meaningful to you about Hispanic/Latine culture. COE looks forward to hearing from you.
|
Cancer Health Equity Collaborative (CHEC) Quarterly Meeting
|
September 28, 2023 | Virtual
|
Join COE for its quarterly Cancer Health Equity Collaborative (CHEC) meeting on Thursday, September 28, 2023, from 10:00 a.m. to 12:00 p.m. This virtual meeting will feature a diverse lineup of speakers who will share their ongoing efforts to promote health equity in California. The agenda includes the Leukemia & Lymphoma Society, the UCSF FANS Study team, the founder of Pink Crescent, and the founder of Gender Phluid Collective.
|
Liver Cancer in San Diego Summit
|
October 28, 2023 | 10:00 a.m. to 12:15 p.m.
|
Save the date for the inaugural Liver Cancer Awareness Summit on Saturday, October 28, 2023. Hosted by Moores, this event will (1) bring together leading experts and professionals to raise awareness of the liver cancer burden and disparities in the San Diego-Baja California region and (2) provide a platform for sharing best practices and advancements in prevention, diagnosis, treatment, and patient care. Registration information will be available next week.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
3855 Health Sciences Drive MC 0698 | La Jolla, CA 92093 US
|
|
|
This email was sent to sjchristie@health.ucsd.edu.
To continue receiving our emails, add us to your address book.
|
|
|
|
